The hemodialysis and peritoneal dialysis market is poised for an evolutionary journey, extending its influence well into 2034 and beyond. The adoption of hemodialysis and peritoneal dialysis is estimated to stand at US$ 104.3 billion in 2024. The market is projected to exceed a valuation of US$ 245 billion by 2034.
The hemodialysis and peritoneal dialysis are anticipated to experience promising growth at a CAGR of 8.9% until 2034. In regions with high rates of diabetes and hypertension, healthcare systems are likely to primarily generate hemodialysis and peritoneal dialysis demand.
| Attributes | Details |
|---|---|
| Estimated Hemodialysis and Peritoneal Dialysis Market Size (2024) | US$ 104.3 billion |
| Forecasted Market Size (2034) | US$ 245 billion |
| Projected Value CAGR (2024 to 2034) | 8.9% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
ESRD Epidemic Spurs Dialysis Concentrate Demand Growth! The primary catalyst driving the market's expansion is the rise in the incidence and prevalence of end-stage renal disease (ESRD).
Technological Breakthroughs Energize Dialysis Market Growth! Technological advancements in dialysis equipment and procedures are fueling the hemodialysis machines market expansion.
Positive Reimbursement Policies Spark Dialysis Adoption! Growing healthcare expenditure and reimbursement policies are supporting the kidney dialysis market growth.
Kidney Health Awareness Spurs Dialysis Market Expansion! Increasing awareness about kidney health and the importance of early intervention is driving the hemodialysis and peritoneal dialysis market growth.
Principal Consultant
Dialysis patients face several primary causes of death, often related to vascular access problems, such as bleeding, infection, low blood pressure, nausea, hernia, hepatitis (B & C), and anemia. Additionally, heart illnesses, encompassing arrhythmic processes or sudden cardiac arrest, contribute to the challenges these patients may encounter. Pneumonia is a frequent side effect of peritoneal dialysis, often triggered by infections from the catheter. This restricts the implementation of dialysis treatments.
With many companies, the dialysis industry is quite competitive and varied. This market is populated by start-up, mid-tier, and tier-I companies. In this fiercely competitive industry, businesses are working to increase their market awareness.
Additionally, many businesses-especially start-ups and small businesses-struggle to thrive and keep up with the industry's growth because of the high capital required for product manufacture and marketing as well as the drawn-out regulatory clearance process. This could make it extremely difficult for a certain business to have a persistent innovation capacity across all market sectors.
From 2019 to 2023, the hemodialysis and peritoneal dialysis market showed impressive growth, boasting an 11.2% CAGR. During this period, renal disease and renal failure were on the rise due to a growing prevalence of diabetes and hypertension. This trend has contributed to the positive outlook of the hemodialysis and peritoneal dialysis industry.
| Attributes | Quantitative Outlook |
|---|---|
| Global Hemodialysis & Peritoneal Dialysis Market Size (2023) | US$ 94.7 billion |
| Historical CAGR (2019 to 2023) | 11.2% |
Short-term Analysis of the Hemodialysis and Peritoneal Dialysis Market
Despite the anticipated decrease in growth rate, the hemodialysis and peritoneal dialysis market global forecast sustained demand due to technological advancements in dialysis equipment and procedures. The introduction of hemodiafiltration, a more recent technique that more effectively removes medium and large water-soluble molecules by convection and diffusion, is anticipated to shake up the market's outlook.
Long-term Analysis of the Hemodialysis and Peritoneal Dialysis Market
The global trends in the hemodialysis and peritoneal dialysis industry spotlight the growing adoption of home-based dialysis solutions, alongside a shift toward personalized treatments designed to meet individual requirements. In June 2023, for the management of patients with either acute or long-term renal failure, the United States-based medical technology company Outset Medical constructed the Tablo® mobile hemodialyzer.
The preclinical technology known as implantable bioartificial kidney (BAK), which aspires to completely replace natural kidney functions, is being developed with the patient's needs in mind. This is expected to have a highly positive impact on the global demand for hemodialysis and peritoneal dialysis products in the long run.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The adoption of value-based healthcare models is expected to present opportunities for market players to innovate and expand their offerings. It emphasizes outcomes and quality of care over traditional fee-for-service arrangements. Technology businesses can provide systems that support remote monitoring, predictive analytics, and data-driven decision-making. These enable clinicians to provide more individualized and effective treatment.
The North America hemodialysis and peritoneal dialysis market stands out as a dominant force. This is because the region boasts advanced healthcare infrastructure and a robust regulatory framework.
Europe is witnessing continuous and steady growth in demand for hemodialysis and peritoneal dialysis consumables. Advancements in technology adoption have led to greater utilization of dialysis therapies.
The Asia Pacific hemodialysis and peritoneal dialysis industry is likely to progress significantly. This is because countries like China, South Korea, and Japan are spending more on healthcare infrastructure.
| Country | United States |
|---|---|
| Forecasted CAGR (2024 to 2034) | 9.2% |
| Projected Market Size by 2034 | US$ 43.5 billion |
| Country | United Kingdom |
|---|---|
| Forecasted CAGR (2024 to 2034) | 9.7% |
| Projected Market Size by 2034 | US$ 9.9 billion |
| Country | China |
|---|---|
| Forecasted CAGR (2024 to 2034) | 9.5% |
| Projected Market Size by 2034 | US$ 38.3 billion |
| Country | Japan |
|---|---|
| Forecasted CAGR (2024 to 2034) | 10.3% |
| Projected Market Size by 2034 | US$ 27.5 billion |
| Country | South Korea |
|---|---|
| Forecasted CAGR (2024 to 2034) | 11.3% |
| Projected Market Size by 2034 | US$ 15.8 billion |
Demand for peritoneal and hemodialysis dialysis equipment in the United States is set to rise with an anticipated CAGR of 9.2% through 2034. Key factors influencing hemodialysis and peritoneal dialyzer demand include:
The United Kingdom hemodialysis and peritoneal dialysis market is expected to surge at a CAGR of 9.7% through 2034. The topmost dynamic forces supporting the hemodialysis and peritoneal dialysis adoption in the country include:
The China hemodialysis and peritoneal dialysis market is forecasted to inflate at a CAGR of 9.5% through 2034. Prominent factors backing up the hemodialysis machines market growth are:
Sales of hemodialysis and peritoneal dialysis equipment in Japan are estimated to record a CAGR of 10.3% through 2034. The primary factors bolstering the market size are:
The market in South Korea is likely to exhibit a CAGR of 11.3% through 2034. Reasons supporting the growth of the hemodialysis and peritoneal dialysis market in the country include:
As far as the type of hemodialysis and peritoneal dialysis is concerned, the hemodialysis segment is likely to dominate through 2034, registering a CAGR of 8.7%. Similarly, the device segment is expected to lead the revenue share of hemodialysis and peritoneal dialysis in terms of product, with a projected CAGR of 8.4% through 2034.
| Segment | Forecasted CAGR (2024 to 2034) |
|---|---|
| Hemodialysis | 8.7% |
| Device | 8.4% |
The hemodialysis segment is anticipated to lead the way, holding an impressive hemodialysis and peritoneal dialysis market share. Here are a few key factors that contribute to hemodialysis’ acceptance in the market:
The device segment takes the top spot in the hemodialysis and peritoneal dialysis market, a dialysis equipment industry trend validated by factors such as:
Hemodialysis and peritoneal dialysis market players employ diverse strategies to gain a competitive edge. Established players like Fresenius Medical Care and B. Braun Melsungen AG dominate, offering comprehensive services and advanced technology.
Meanwhile, in peritoneal dialysis, Baxter International leads with its innovative solutions for home-based treatment. Emerging players such as NxStage Medical and Medtronic are gaining traction, focusing on portable dialysis machines and simplifying treatment processes.
Recent Developments
The market size for hemodialysis and peritoneal dialysis is forecasted to be worth US$ 104.3 billion in 2024.
The value of the hemodialysis and peritoneal dialysis market is projected to surpass US$ 245 billion by 2034.
The CAGR of the hemodialysis and peritoneal dialysis industry is estimated to be around 8.9% through 2034.
Increasing adoption of home-based dialysis is a key dialysis equipment trend in the market.
The United States, China, and Japan are key consumers of hemodialysis and peritoneal dialysis devices and consumables as of 2024.
Baxter, B. Braun Melsungen AG, and Fresenius Medical Care AG are hemodialysis and peritoneal dialysis industry leaders.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034 4.1. Historical Market Size Value (US$ Million) Analysis, 2019 to 2023 4.2. Current and Future Market Size Value (US$ Million) Projections, 2024 to 2034 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Type, 2019 to 2023 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type, 2024 to 2034 5.3.1. Hemodialysis 5.3.1.1. Conventional hemodialysis 5.3.1.2. Short daily hemodialysis 5.3.1.3. Nocturnal hemodialysis 5.3.2. Peritoneal dialysis 5.3.2.1. Continuous Ambulatory Peritoneal Dialysis (CAPD) 5.3.2.2. Automated Peritoneal Dialysis (APD) 5.4. Y-o-Y Growth Trend Analysis By Type, 2019 to 2023 5.5. Absolute $ Opportunity Analysis By Type, 2024 to 2034 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Product, 2019 to 2023 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2024 to 2034 6.3.1. Device 6.3.1.1. Machine 6.3.1.2. Dialyzer 6.3.1.3. Water treatment system 6.3.1.4. Others 6.3.2. Consumables 6.3.2.1. Bloodline 6.3.2.2. Concentrates 6.3.2.3. Catheters 6.3.2.4. Others 6.4. Y-o-Y Growth Trend Analysis By Product, 2019 to 2023 6.5. Absolute $ Opportunity Analysis By Product, 2024 to 2034 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End-use 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By End-use, 2019 to 2023 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-use, 2024 to 2034 7.3.1. Home-based 7.3.2. Hospital-based 7.4. Y-o-Y Growth Trend Analysis By End-use, 2019 to 2023 7.5. Absolute $ Opportunity Analysis By End-use, 2024 to 2034 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2019 to 2023 8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2024 to 2034 8.3.1. North America 8.3.2. Latin America 8.3.3. Western Europe 8.3.4. Eastern Europe 8.3.5. South Asia and Pacific 8.3.6. East Asia 8.3.7. Middle East and Africa 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 9.2.1. By Country 9.2.1.1. USA 9.2.1.2. Canada 9.2.2. By Type 9.2.3. By Product 9.2.4. By End-use 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Type 9.3.3. By Product 9.3.4. By End-use 9.4. Key Takeaways 10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Type 10.2.3. By Product 10.2.4. By End-use 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Type 10.3.3. By Product 10.3.4. By End-use 10.4. Key Takeaways 11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. UK 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Western Europe 11.2.2. By Type 11.2.3. By Product 11.2.4. By End-use 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Type 11.3.3. By Product 11.3.4. By End-use 11.4. Key Takeaways 12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 12.2.1. By Country 12.2.1.1. Poland 12.2.1.2. Russia 12.2.1.3. Czech Republic 12.2.1.4. Romania 12.2.1.5. Rest of Eastern Europe 12.2.2. By Type 12.2.3. By Product 12.2.4. By End-use 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Type 12.3.3. By Product 12.3.4. By End-use 12.4. Key Takeaways 13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 13.2.1. By Country 13.2.1.1. India 13.2.1.2. Bangladesh 13.2.1.3. Australia 13.2.1.4. New Zealand 13.2.1.5. Rest of South Asia and Pacific 13.2.2. By Type 13.2.3. By Product 13.2.4. By End-use 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Type 13.3.3. By Product 13.3.4. By End-use 13.4. Key Takeaways 14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 14.2.1. By Country 14.2.1.1. China 14.2.1.2. Japan 14.2.1.3. South Korea 14.2.2. By Type 14.2.3. By Product 14.2.4. By End-use 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Type 14.3.3. By Product 14.3.4. By End-use 14.4. Key Takeaways 15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Israel 15.2.1.4. Rest of MEA 15.2.2. By Type 15.2.3. By Product 15.2.4. By End-use 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Type 15.3.3. By Product 15.3.4. By End-use 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. USA 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2023 16.1.2.1. By Type 16.1.2.2. By Product 16.1.2.3. By End-use 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2023 16.2.2.1. By Type 16.2.2.2. By Product 16.2.2.3. By End-use 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2023 16.3.2.1. By Type 16.3.2.2. By Product 16.3.2.3. By End-use 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2023 16.4.2.1. By Type 16.4.2.2. By Product 16.4.2.3. By End-use 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2023 16.5.2.1. By Type 16.5.2.2. By Product 16.5.2.3. By End-use 16.6. UK 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2023 16.6.2.1. By Type 16.6.2.2. By Product 16.6.2.3. By End-use 16.7. France 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2023 16.7.2.1. By Type 16.7.2.2. By Product 16.7.2.3. By End-use 16.8. Spain 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2023 16.8.2.1. By Type 16.8.2.2. By Product 16.8.2.3. By End-use 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2023 16.9.2.1. By Type 16.9.2.2. By Product 16.9.2.3. By End-use 16.10. Poland 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2023 16.10.2.1. By Type 16.10.2.2. By Product 16.10.2.3. By End-use 16.11. Russia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2023 16.11.2.1. By Type 16.11.2.2. By Product 16.11.2.3. By End-use 16.12. Czech Republic 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2023 16.12.2.1. By Type 16.12.2.2. By Product 16.12.2.3. By End-use 16.13. Romania 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2023 16.13.2.1. By Type 16.13.2.2. By Product 16.13.2.3. By End-use 16.14. India 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2023 16.14.2.1. By Type 16.14.2.2. By Product 16.14.2.3. By End-use 16.15. Bangladesh 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2023 16.15.2.1. By Type 16.15.2.2. By Product 16.15.2.3. By End-use 16.16. Australia 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2023 16.16.2.1. By Type 16.16.2.2. By Product 16.16.2.3. By End-use 16.17. New Zealand 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2023 16.17.2.1. By Type 16.17.2.2. By Product 16.17.2.3. By End-use 16.18. China 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2023 16.18.2.1. By Type 16.18.2.2. By Product 16.18.2.3. By End-use 16.19. Japan 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2023 16.19.2.1. By Type 16.19.2.2. By Product 16.19.2.3. By End-use 16.20. South Korea 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2023 16.20.2.1. By Type 16.20.2.2. By Product 16.20.2.3. By End-use 16.21. GCC Countries 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2023 16.21.2.1. By Type 16.21.2.2. By Product 16.21.2.3. By End-use 16.22. South Africa 16.22.1. Pricing Analysis 16.22.2. Market Share Analysis, 2023 16.22.2.1. By Type 16.22.2.2. By Product 16.22.2.3. By End-use 16.23. Israel 16.23.1. Pricing Analysis 16.23.2. Market Share Analysis, 2023 16.23.2.1. By Type 16.23.2.2. By Product 16.23.2.3. By End-use 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Type 17.3.3. By Product 17.3.4. By End-use 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Baxter 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.2. B. Braun Melsungen AG 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.3. Fresenius Medical Care AG 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.4. Medtronic 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.5. Asahi Kasei Medical Co., Ltd. 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.6. Nipro Corp. 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.7. DaVita 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.8. BD 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.9. Nikkiso Co., Ltd. 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.10. Cantel Medical 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Healthcare
November 2023
REP-GB-18512
371 pages
Explore Healthcare Insights
View Reports
Hemodialysis and Peritoneal Dialysis Market
